SCHEMBL13899151

SCHEMBL13899151

CC(=O)C(C)CC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20013272 1.00
SCHEMBL27650966 0.83
Phenol SCHEMBL28766018 0.80 ESRRB (0.42)
SCHEMBL23381280 0.80
SCHEMBL7354603 0.80
SCHEMBL3052834 0.80
SCHEMBL6692725 0.79
SCHEMBL20804159 0.79
SCHEMBL26857861 0.79
SCHEMBL25616126 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368262-A1 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO Prism BioLab Co., Ltd. (JP) 2015-12-24 US disclosed
US-9040531-B2 Alpha helix mimetics and methods relating thereto Prism BioLab Co., Ltd. (JP) 2015-05-26 US disclosed
EP-2379580-B1 NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS CUBIST PHARM INC (US) 2013-10-23 EP disclosed
US-7511154-B2 Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts BASILEA PHARMACEUTICALS AG (CH) 2009-03-31 US disclosed
US-20080009637-A1 Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts BASILEA PHARMACEUTICA AG 2008-01-10 US disclosed
US-7262307-B2 1′-benzyl-3-bromo-[1,3′]bipyrrolidinyl-2-one BASILEA PHARMACEUTICA AG (CH) 2007-08-28 US disclosed